Literature DB >> 20436169

Steroids in COPD: still up in the air?

D D Sin, S F P Man.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20436169     DOI: 10.1183/09031936.00006710

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  9 in total

Review 1.  Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature.

Authors:  Ho Il Yoon; Don D Sin
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

Review 2.  Bronchiectasis in older patients with chronic obstructive pulmonary disease : prevalence, diagnosis and therapeutic management.

Authors:  Deborah Whitters; Robert A Stockley
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

Review 3.  Inhaled corticosteroids for stable chronic obstructive pulmonary disease.

Authors:  Ian A Yang; Melissa S Clarke; Esther H A Sim; Kwun M Fong
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

4.  Chronic obstructive pulmonary disease hospital admissions and drugs--unexpected positive associations: a retrospective general practice cohort study.

Authors:  Timothy H Harries; Paul T Seed; Simon Jones; Peter Schofield; Patrick White
Journal:  NPJ Prim Care Respir Med       Date:  2014-05-20       Impact factor: 2.871

5.  The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.

Authors:  Guy Brusselle; David Price; Kevin Gruffydd-Jones; Marc Miravitlles; Dorothy L Keininger; Rebecca Stewart; Michael Baldwin; Rupert C Jones
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-10-15

6.  Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO).

Authors:  Andrea Rossi; Massimo Guerriero; Antonio Corrado
Journal:  Respir Res       Date:  2014-07-08

Review 7.  Poly(ADP-Ribose)Polymerase-1 in Lung Inflammatory Disorders: A Review.

Authors:  Gurupreet S Sethi; Vivek Dharwal; Amarjit S Naura
Journal:  Front Immunol       Date:  2017-09-19       Impact factor: 7.561

8.  Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy.

Authors:  Giuseppe Antonio Palmiotti; Donato Lacedonia; Vito Liotino; Pietro Schino; Francesco Satriano; Pier Luigi Di Napoli; Eugenio Sabato; Vincenzo Mastrosimone; Alfredo Scoditti; Mauro Carone; Elio Costantino; Emanuela Resta; Ettore Attolini; Maria Pia Foschino Barbaro
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-08-15

9.  Overtreatment of COPD with inhaled corticosteroids--implications for safety and costs: cross-sectional observational study.

Authors:  Patrick White; Hannah Thornton; Hilary Pinnock; Sofia Georgopoulou; Helen P Booth
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.